People who paid out of pocket or through insurance for covered generic medicines between May 1, 2009 and December 31, 2019 may qualify to claim a share of $533 million from the generics price-fixing end-payer settlements with Sandoz/Fougera, Sun/Taro and Apotex/Heritage. Claims close November 9, 2026 and require purchase records, receipts or insurer statements.
Current Status
Claims are open. The deadline to file an end-payer claim, online or by mail, is November 9, 2026. All three settlements in this claim have final approval: Sandoz/Fougera ($275 million, approved September 26, 2025), Sun/Taro ($200 million, approved January 23, 2026) and Apotex/Heritage ($58 million, approved in late 2025). One claim covers all three. No payment date had been announced as of October 1, 2026.This page covers the end-payer class action only. The state attorneys general run a separate consumer program with its own website and a later deadline of March 8, 2027; it is explained on its own page, the state attorneys general consumer settlement. Filing here does not file you there, and the November 9 deadline comes first.
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
What Changed Recently?
Class counsel combined the three finally approved end-payer settlements into one claims process, which opened in 2026 with a November 9, 2026 deadline. In September 2026 the state attorneys general also opened their own consumer claims process, with a March 8, 2027 deadline. That second program is a separate claim with separate money, which is why two deadlines appear in coverage of these settlements.Which Program Is This?
Three separate legal tracks grew out of the same alleged price-fixing, and each has its own website and claim:| Program | Who It Is For | Money | Deadline |
|---|---|---|---|
| End-payer class action (this page) · official end-payer settlement website | Consumers and health plans that paid for covered generics | $533M from Sandoz/Fougera, Sun/Taro, Apotex/Heritage | November 9, 2026 |
| State attorneys general consumer program | Individual consumers | About $96.5M from Apotex, Heritage, Lannett, Bausch, Glenmark | March 8, 2027 |
| Direct purchaser class action | Pharmacies, wholesalers and distributors only | Separate settlements | Not for consumers |
A consumer who qualifies for both consumer programs can file in both, but each needs its own claim.
Who Qualifies?
The end-payer classes cover consumers who paid all or part of the cost of covered generic medicines in the United States between May 1, 2009 and December 31, 2019, whether out of pocket, through a copay or through coinsurance, plus health insurers, employer plans and union benefit funds that reimbursed those costs. Consumers and third-party payers each have their own claim path.The covered products include hundreds of common generic medicines, including widely used generics for blood pressure, heart conditions, cholesterol, diabetes, thyroid conditions, asthma, infections and depression. Check the full list on the official settlement website or in our covered generics list.
How Much Can You Get?
The three end-payer settlements total $533 million:| Settlement | Amount | Status |
|---|---|---|
| Sandoz / Fougera | $275,000,000 | Final approval September 26, 2025 · claims open |
| Sun / Taro | $200,000,000 | Final approval January 23, 2026 · claims open |
| Apotex / Heritage | $58,000,000 | Final approval late 2025 · claims open |
Payments are pro rata. What each claimant receives depends on how much was paid for covered generics and on the total value of valid claims, after court-approved fees and costs. No per-person amount has been announced.
What Proof Is Required?
Proof is required. You need records showing the covered generics you paid for during the class period, such as pharmacy purchase histories, receipts, insurer explanation-of-benefits statements or account statements. Most pharmacies can print a purchase history covering past years. Gather the records before you start the claim.What Is the Deadline?
Submit the end-payer claim online or postmarked by November 9, 2026. Dates can change by court order, so confirm on the official settlement website. The separate state attorneys general consumer program has a different deadline, March 8, 2027, and needs its own claim on its own website.How Do You File?
File online at the official end-payer settlement website or by mail. Choose the consumer or third-party payer path, list the covered generics you paid for, and attach your records. You do not need to sign up with or pay a claims-recovery firm; class counsel told the court in November 2025 that some outside firms were sending misleading solicitations.What Is the Case About?
Dozens of generic manufacturers are accused of conspiring to fix prices, allocate customers and rig bids for hundreds of generics between 2009 and 2019, instead of competing on price. The complaints allege that consumers and health plans paid more than they should have for everyday generics. The federal class actions are consolidated in In re Generic Pharmaceuticals Pricing Antitrust Litigation, No. 16-MD-2724, in the Eastern District of Pennsylvania before Judge Cynthia M. Rufe. The defendants deny the allegations, and many, including Teva, Actavis, Amneal, Lupin, Mallinckrodt and Viatris, have not settled.Sandoz has also been the subject of separate state actions. On February 2, 2026, a coalition of states sued Novartis AG and the Sandoz entities over 31 additional generics, and in August 2026 a coalition of 43 states and territories announced a $400 million settlement in principle with Sandoz. These are allegations; no finding of liability has been made. That state deal is not part of this end-payer claim or the current state consumer distribution.
What Happens Next?
Claims close November 9, 2026. The administrator then reviews claims and calculates pro rata payments; no payment date had been announced as of October 1, 2026. Litigation continues against the companies that have not settled, so further settlements are possible.Sources and Verification
- Official end-payer settlement website — official end-payer settlement website
- End-payer class counsel Fine, Kaplan and Black, R.P.C., claim-forms notice (July 2026)
- In re Generic Pharmaceuticals Pricing Antitrust Litigation, No. 16-MD-2724 (E.D. Pa.), final approval orders for the Sandoz/Fougera, Sun/Taro and Apotex/Heritage settlements
- State attorneys general consumer program — covered on its own page, the state AG consumer settlement
Questions
Can I file a claim in the generics settlement right now?
Yes. Claims are open for the combined end-payer settlements with Sandoz/Fougera, Sun/Taro and Apotex/Heritage, and the deadline is November 9, 2026. File online at the official end-payer settlement website or by mail.
Why do I keep seeing a March 8, 2027 deadline?
That is a different program. The state attorneys general run a separate consumer program, with its own website, its own claim form and a March 8, 2027 deadline, funded by about $96.5 million from Apotex, Heritage, Lannett, Bausch and Glenmark. It does not include the Sandoz money. Filing in one program does not file you in the other, and the end-payer deadline of November 9, 2026 comes first.
Is the $275 million Sandoz and Fougera settlement part of this claim?
Yes. The $275 million settlement with Sandoz and its subsidiary Fougera is one of the three end-payer settlements in this combined claim, alongside Sun/Taro ($200 million) and Apotex/Heritage ($58 million). One end-payer claim covers all three, and the deadline is November 9, 2026.
Who qualifies for the end-payer settlements?
Consumers who paid all or part of the cost of covered generics in the United States between May 1, 2009 and December 31, 2019, and health insurers, employer plans and union benefit funds that reimbursed those costs. The covered generics are listed on the official settlement website.
What proof do I need for an end-payer claim?
You need records of the covered generics you paid for during the class period, such as pharmacy purchase histories, receipts, insurer explanation-of-benefits statements or account statements. Gather them before you start the claim.
How much money is in the end-payer settlements?
$533 million in total: $275 million from Sandoz/Fougera, $200 million from Sun/Taro and $58 million from Apotex and Heritage. Payments are pro rata, so the amount per claimant depends on how much was paid for covered generics and how many valid claims are filed. No per-person amount has been announced.
